Search
for
Sort by
Research 31–60 of 116
- Cutaneous Reactions to Drugs
- Dermatologic Adverse Events from Cancer Treatments
- Skin
- Dermatologic Care of the Transplant Patient
- Chemotherapy and Cutaneous Drug Reactions
- Cutaneous drug reactions
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Trichilemmal Carcinoma of the Thigh
- Present Chemotherapy Induced Alopecia and Research in Future
- Sorafenib-induced Facial Acneiform Eruption
- Periungual lesions secondary to chemotherapy with docetaxel
- Chemically Induced Hair Loss/Alopecia
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Poster Abstracts
- Table of Contents
- Index
- Abnormal fingerprints and immigration delay disease
- INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Prophylaxis and Management of Skin Toxicities
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Rare Case of Alopecia: Alopecia Neoplastica
- Effect of a medicinal and edible decoction YH0618 on chemotherapy-induced dermatologic toxicity: a randomized controlled trial
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Qualitative and Quantitative Assessment of Taste and Smell Changes in Patients Undergoing Chemotherapy for Breast Cancer or Gynecologic Malignancies
- Epigenetics of Colorectal Cancer
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Protein Kinase C as a Therapeutic Target
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study